SEC Filings
United Therapeutics Authorizes Another $2 Billion Buyback, Separate From Its Running Repurchase
The new program runs through October 21, 2027 and sets no minimum purchase, while a September accelerated repurchase continues.
SEC Filings
The new program runs through October 21, 2027 and sets no minimum purchase, while a September accelerated repurchase continues.
SEC Filings
The company also filed for a second Onapgo supplier and still expects potential FDA approval of it by mid-year 2027.
SEC Filings
The circuit-board maker's CEO said adjusted EBITDA margin passed 20% for the first time, with Data Center & Networking up 115%.
SEC Filings
The cooperation agreement enlarges the board from nine to ten seats and ties Mattel's obligations to EdgePoint keeping at least 10% of the stock.
SEC Filings
A joint SEC filing lists 22.9 million shares, with 4.3% held by the Citadel broker-dealer and the rest spread across affiliates.
SEC Filings
The 6 million new shares equal 13.5% of the stock outstanding after the offering, and the money is meant for trials and a possible bitopertin launch.
SEC Filings
Cadeler plc gave holders a week more to tender into its one-for-one exchange offer, which carries a 90% minimum-acceptance condition.
SEC Filings
A $56 million valuation allowance release helped lift per-share profit as revenue and operating income both fell, the 10-Q shows.
SEC Filings
The 10-Q sets a $75 million ceiling on the 2026 program, which has already booked $65 million, with branch closures the largest piece.
SEC Filings
Matheson stays on as an advisor to the CEO through July 15, 2027, and Kaz Nejatian's pay is not expected to change.
SEC Filings
The 10-Q applies held-for-sale accounting as of September 30 and expects about $2,000 million in cash at closing.
SEC Filings
The seat comes from the investor agreement signed when Tessenderlo bought $403,244,907.80 of newly issued FMC stock.